Iqbal Khan Joins CAM: Powering the Future of Corporate Law
Iqbal Khan, one of India’s top private equity and M&A lawyers, has officially joined Cyril Amarchand Mangaldas (CAM) as a Partner in its Corporate Practice, bringing along a team of approximately 18–20 lawyers. This strategic lateral hire is reshaping CAM’s deal-making power in Mumbai—and across India’s corporate legal landscape.
Also Read: Nishith Mehta Joins CAM as Head – Financial Regulatory & Compliance
Who Is Iqbal Khan?
Iqbal Khan joined J Sagar Associates (JSA) in October 2024 after a successful stint at Shardul Amarchand Mangaldas (SAM), where he spent nearly a decade working on high-profile PE and M&A deals.
He holds a JD from Columbia Law School (Harlan Fiske Stone Scholar) and an LLB from LSE, and has international experience at Paul Weiss and Kirkland & Ellis in the U.S. . His practice covers PE investments, joint ventures, mergers & acquisitions, especially in sectors like life sciences, healthcare, technology, and infrastructure.
The Move to CAM
CAM, India’s largest full-service firm with over 700 lawyers and six offices nationwide, welcomes Khan into its thriving Corporate/M&A and Private Equity practice.
This move brings:
Khan and his 18–20-strong team relocating to CAM’s Mumbai office
An immediate boost to CAM’s M&A and PE bench, with deeper expertise and historic deal relationships
JSA Confirms Departure
JSA has officially acknowledged Khan’s resignation and transition:
“Iqbal Khan has communicated his resignation to JSA. The exit modalities will be worked out mutually… the firm will continue to aggressively pursue its growth path and wishes Iqbal well.” — Vivek K. Chandy, JSA Joint Managing Partner
The firm also confirmed that key colleagues, such as Ambarish (who joined JSA from SAM alongside Khan), are among those moving.
What This Means for CAM
Expanded PE/M&A Muscle: Khan’s arrival reinforces CAM’s front-end capabilities in high-stakes deal-making.
Team-based Growth: Bringing a cohesive team allows CAM to helm larger, multi-sector corporate transactions.
Strategic Market Insight: Khan’s deep industry network (APAC, life sciences, tech) complements CAM’s cross-border ambitions.
Sector & Deal Insights
Khan’s high-profile closures include deals involving TPG, Biocon, Serum Institute, LIC, PharmEasy, and Reliance. At CAM, he’s expected to drive similar high-impact transactions across:
Private Equity exits and investments
JV formations
Cross-border M&A
Regulatory-heavy sector deals
What’s Next
Expect CAM to:
Leverage the new corporate bench in upcoming financial year deals
Expand transaction capabilities in health tech, infrastructure, PE-backed businesses
Boost executive-level deal flow with transnational and private equity partners
For Khan, it’s a moment to flex his leadership with larger deal pipelines and deeper strategic influence—no longer a newcomer but a core partner at one of India’s top firms.
This move isn’t just a lateral hire—it’s a strategic reinforcement of CAM’s position in India’s corporate law space. With Iqbal Khan and his team on board, CAM’s private equity and M&A practice is stronger, sharper, and better equipped for the evolving complexities of domestic and cross-border deals.
Also Read: Iqbal Khan Steps Down from JSA: A Bold Move That Could Reshape CAM’s Corporate Practice
Disclaimer:
The information provided in this article is based on publicly available sources. While care has been taken to ensure accuracy, developments are ongoing and final confirmations may vary. This article is intended for informational and journalistic purposes only and does not constitute legal advice.
